R&D Driving the drug discovery pipeline: The value of organ-on-a... In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Tomasz Kostrzewski, CSO at CN Bio, about single organ-on-a-chip technology.
Partner Content Partner Content TissUse GmbH to discuss multi-organ-on-a-chip technologies a... SMi reports: Reyk Horland, Vice President, Business Development at TissUse GmbH to discuss “Applying Multi-Organ-on-a-Chip Technologies for Predictive Substance Testing" at SMi’s Drug Discovery con
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.